• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人深静脉血栓形成中的马尔堡I多态性(G511E)

Marburg I Polymorphism (G511E) in Adults with Deep Vein Thrombosis.

作者信息

Kumar Narender, Sundaram Archana, Rani Neetu, Ahluwalia Jasmina, Das Reena, Varma Neelam, Suri Vikas, Malhotra Pankaj

机构信息

1Department of Hematology, Level 5, Research Block A, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012 India.

2Pathology (Group C) Departments, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012 India.

出版信息

Indian J Hematol Blood Transfus. 2020 Jan;36(1):183-186. doi: 10.1007/s12288-019-01146-1. Epub 2019 Jun 12.

DOI:10.1007/s12288-019-01146-1
PMID:32158102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7042457/
Abstract

The Marburg I polymorphism (G511E) in gene was listed as one of the risk factor for idiopathic DVT among the western population. The frequency of Marburg I polymorphism in India is presently not known. Fifty DVT cases and 50 healthy controls were tested for Marburg I polymorphism using ARMS-PCR technique. The thrombophilic risk factors (Protein C, Protein S, Antithrombin III, Factor V Leiden and antiphospholipid antibodies) were also determined. Marburg I polymorphism (heterozygous) was found in 2 patients (4%) but not in control subjects. These two cases did not have any other thrombophilia markers. Among the thrombophilic markers, heterozygous FVL mutation, PS, PC, AT deficiencies and antiphospholipid antibodies were seen in 10%, 10%, 6%, 6% and 8% of the patients respectively. The controls showed only the presence of antiphospholipid antibodies in 6% of subjects. Marburg I polymorphism among Indians DVT patients was determined for the first time. Its incidence was found in 4% of cases and not in controls. Although not statically significant this may be considered as one of the contributory risk factors for the development of DVT. A larger study is required for the validation of data.

摘要

基因中的马尔堡I多态性(G511E)被列为西方人群特发性深静脉血栓形成的危险因素之一。目前尚不清楚印度马尔堡I多态性的频率。采用扩增阻滞突变系统聚合酶链反应(ARMS-PCR)技术对50例深静脉血栓形成患者和50例健康对照者进行马尔堡I多态性检测。同时还测定了血栓形成倾向危险因素(蛋白C、蛋白S、抗凝血酶III、凝血因子V莱顿和抗磷脂抗体)。2例患者(4%)发现马尔堡I多态性(杂合子),而对照者未发现。这两例患者没有任何其他血栓形成倾向标志物。在血栓形成倾向标志物中,分别有10%、10%、6%、6%和8%的患者出现杂合子FVL突变、蛋白S、蛋白C、抗凝血酶III缺乏和抗磷脂抗体。对照组仅6%的受试者存在抗磷脂抗体。首次确定了印度深静脉血栓形成患者中的马尔堡I多态性。其发生率在4%的病例中发现,而对照者未发现。尽管无统计学意义,但这可被视为深静脉血栓形成发展的促成危险因素之一。需要进行更大规模的研究来验证数据。

相似文献

1
Marburg I Polymorphism (G511E) in Adults with Deep Vein Thrombosis.成人深静脉血栓形成中的马尔堡I多态性(G511E)
Indian J Hematol Blood Transfus. 2020 Jan;36(1):183-186. doi: 10.1007/s12288-019-01146-1. Epub 2019 Jun 12.
2
[Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].[深静脉血栓形成患者的活化蛋白C抵抗、莱顿突变、抗凝蛋白及纤维蛋白原水平]
Pol Arch Med Wewn. 2003 Jun;109(6):579-88.
3
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.基因编码的 VII 因子激活蛋白酶的 G534E 多态性是静脉血栓形成和复发事件的危险因素。
Thromb Res. 2012 Sep;130(3):441-4. doi: 10.1016/j.thromres.2012.02.009. Epub 2012 Mar 14.
4
Thrombophilia testing in patients with venous thrombosis.静脉血栓形成患者的血栓形成倾向检测。
Eur J Vasc Endovasc Surg. 2005 Nov;30(5):550-5. doi: 10.1016/j.ejvs.2005.05.034. Epub 2005 Aug 1.
5
Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India.印度西部大量妊娠队列中的产前深静脉血栓形成。
Thromb J. 2007 Jul 4;5:9. doi: 10.1186/1477-9560-5-9.
6
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.凝血因子V莱顿突变和抗磷脂抗体是儿童缺血性卒中的重要危险因素。
Stroke. 2000 Jun;31(6):1283-8. doi: 10.1161/01.str.31.6.1283.
7
Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.上肢原发性深静脉血栓形成的危险因素及复发率
Circulation. 2004 Aug 3;110(5):566-70. doi: 10.1161/01.CIR.0000137123.55051.9B. Epub 2004 Jul 19.
8
Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.凝血酶原20210A等位基因和因子V莱顿突变对伴有其他止血缺陷的易栓症家族血栓形成风险的影响。
Haematologica. 2001 Nov;86(11):1200-8.
9
Thrombophilic conditions in non-cirrhotic portal vein thrombosis.非肝硬化门静脉血栓形成中的血栓形成倾向状况
Indian J Gastroenterol. 2005 Sep-Oct;24(5):205-10.
10
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.静脉血栓栓塞症不同临床表现的血栓形成倾向模式:443 例静脉血栓栓塞症调查。
Semin Thromb Hemost. 2012 Mar;38(2):230-4. doi: 10.1055/s-0032-1301420. Epub 2012 Feb 8.

引用本文的文献

1
Prothrombin G20210A Mutation is Rare but not Absent Among North Indian Patients with Thromboembolic Events.凝血酶原G20210A突变在北印度血栓栓塞事件患者中罕见但并非不存在。
Indian J Hematol Blood Transfus. 2024 Jul;40(3):522-526. doi: 10.1007/s12288-024-01741-x. Epub 2024 Mar 25.

本文引用的文献

1
Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.印度北部静脉血栓栓塞患者的凝血因子VIII、IX和XI水平:印度的首次研究。
Blood Coagul Fibrinolysis. 2016 Jan;27(1):58-63. doi: 10.1097/MBC.0000000000000390.
2
Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.血栓形成性原发性抗磷脂综合征:印度北部患者的抗体阳性情况
Int J Rheum Dis. 2016 Sep;19(9):903-12. doi: 10.1111/1756-185X.12479. Epub 2014 Oct 8.
3
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.基因编码的 VII 因子激活蛋白酶的 G534E 多态性是静脉血栓形成和复发事件的危险因素。
Thromb Res. 2012 Sep;130(3):441-4. doi: 10.1016/j.thromres.2012.02.009. Epub 2012 Mar 14.
4
Differences in etiological and clinical manifestations in upper extremity and lower limb deep venous thrombosis patients from India.印度上肢和下肢深静脉血栓形成患者病因和临床表现的差异。
Clin Appl Thromb Hemost. 2010 Dec;16(6):698-700. doi: 10.1177/1076029609351290. Epub 2009 Nov 10.
5
Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India.印度西部大量妊娠队列中的产前深静脉血栓形成。
Thromb J. 2007 Jul 4;5:9. doi: 10.1186/1477-9560-5-9.
6
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.凝血因子 VII 激活蛋白酶的马尔堡 I 多态性与复发性静脉血栓栓塞风险
Thromb Haemost. 2006 Jan;95(1):65-7.
7
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis.
Blood. 2005 Jun 15;105(12):4898; author reply 4899. doi: 10.1182/blood-2005-02-0576.
8
Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism.凝血因子 VII 激活蛋白酶的马尔堡 I 多态性与特发性静脉血栓栓塞症相关。
Blood. 2005 Feb 15;105(4):1549-51. doi: 10.1182/blood-2004-08-3328. Epub 2004 Oct 14.
9
Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism.印度北部静脉血栓栓塞症患者中凝血因子V莱顿突变的异质性分布。
J Thromb Haemost. 2003 Jun;1(6):1329-30. doi: 10.1046/j.1538-7836.2003.00185.x.
10
The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).常见的马尔堡I多态性会损害凝血因子VII激活蛋白酶(FSAP)的尿激酶原激活能力。
Blood Coagul Fibrinolysis. 2002 Jul;13(5):433-41. doi: 10.1097/00001721-200207000-00008.